Webinars

We host regular webinars covering topics in breast disease and breast cancer research, diagnosis and management.

Next Session

Scottish Breast Research Legacy

Speaker: David Cameron, Professor of Oncology, Edinburgh Cancer Centre
Date: Friday 4th September 2026
Time: 13:10 – 13:50
Platform: Microsoft Teams
Registration: Register here
In this opening webinar from SBSG, Professor David Cameron will reflect on the legacy of breast clinical trials in Scotland and lay out his vision for future collaborative breast research in Scotland and present the opportunities for Scottish Breast Units to participate as partners in global research programmes.

Date	Speaker	Topic
4 September 2026	David Cameron (Edinburgh)	Scottish Breast Research Legacy: Scotland’s contribution to breast cancer clinical research, from landmark trials of breast-conserving treatment and adjuvant therapy to contemporary international studies.
October 2026 (date to be confirmed)	Rob Stein (to be confirmed)	OPTIMA trial: Using tumour gene-expression testing to determine whether people with hormone-sensitive, HER2-negative early breast cancer can safely avoid chemotherapy after surgery.
October 2026 (date to be confirmed)	Sarah Savaridas (Dundee)	Trial in Progress: CESAR trial: A multicentre study comparing contrast-enhanced mammography with MRI for assessing breast cancer response to neoadjuvant chemotherapy.
6 November 2026	Iain MacPherson	HER2-RADiCAL trial: Investigating whether people with early HER2-positive breast cancer who respond completely to treatment before surgery can safely receive less drug treatment afterwards.
7 December 2026	Joel Allotey and Sylvia Kamya	SPRINT Study (Cardio-oncology): How anthracycline chemotherapy affects heart and skeletal-muscle function in people with early breast cancer, and approaches to reducing treatment-related impairment and fatigue.
January 2027 (provisionally 18 or 25 January)	Vassilis Pitsinis and colleagues (Dundee)	ICG tracer research: Using indocyanine green fluorescence as a non-radioactive tracer to identify sentinel lymph nodes during surgery for early breast cancer.